Tiliacora triandra Leaf Powder Ethanolic Extract in Combination with Cisplatin or Gemcitabine Synergistically Inhibits the Growth of Cholangiocarcinoma Cells In Vitro and in Nude Mouse Xenograft Models

Medicina (Kaunas). 2023 Jul 7;59(7):1269. doi: 10.3390/medicina59071269.

Abstract

Background and Objectives: The treatments of cholangiocarcinoma (CCA) with Cisplatin (Cis) and Gemcitabine (Gem) often cause side effects and drug resistance. This study aimed to investigate the combined effects of Tiliacora triandra leaf powder ethanolic extract (TLPE) and Cis or Gem on CCA cells in vitro and in nude mouse xenografts. Materials and Methods: Antiproliferative activity was evaluated using MTT assay. Drug interaction was studied by Chou-Talalay method. Apoptosis induction and cell cycle arrest were analyzed by flow cytometry. Cell cycle and apoptosis regulating proteins were evaluated by western blot analysis. Results:Treatments with Cis or Gem in combination with TLPE significantly inhibited the growth of KKU-M213B and KKU-100 cells compared with single drug treatments. Synergistic drug interactions were observed with the dose reduction of Cis and Gem treatments. The safety of TLPE was demonstrated in vitro by the hemolytic assay. Synergistic combination treatments down-regulated Bcl2 and reduced the ratio of Bcl2/Bax in both CCA cells. TLPE enhanced tumor suppression of both Cis and Gem in nude mouse xenograft models. Combination treatments with Cis and TLPE reduced Cis toxicity, as demonstrated by the enhanced body weight change of the treated mice compared with the treatment with Cis alone. Furthermore, TLPE reduced hepatotoxicity caused by Gem treatment and reduced kidney and spleen toxicities caused by Cis treatment. Conclusion: These findings suggest that TLPE enhances the anticancer activity of Cis and Gem and reduces their toxicity both in vitro and in nude mouse xenograft models.

Keywords: Tiliacora triandra; anticancer activity; cholangiocarcinoma; cisplatin; drug combination; gemcitabine.

MeSH terms

  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Apoptosis
  • Bile Duct Neoplasms* / drug therapy
  • Bile Ducts, Intrahepatic
  • Cell Line, Tumor
  • Cell Proliferation
  • Cholangiocarcinoma* / drug therapy
  • Cisplatin / pharmacology
  • Cisplatin / therapeutic use
  • Deoxycytidine / pharmacology
  • Deoxycytidine / therapeutic use
  • Gemcitabine
  • Heterografts
  • Humans
  • Mice
  • Mice, Nude
  • Powders / pharmacology
  • Powders / therapeutic use
  • Proto-Oncogene Proteins c-bcl-2

Substances

  • Gemcitabine
  • Cisplatin
  • Powders
  • Deoxycytidine
  • Proto-Oncogene Proteins c-bcl-2